Analysts expect that MAXIMUS, Inc. (NYSE:MMS) will report $0.93 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Four analysts have made estimates for MAXIMUS’s earnings, with the lowest EPS estimate coming in at $0.90 and the highest estimate coming in at $0.97. MAXIMUS reported earnings of $0.91 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 2.2%. The firm is expected to announce its next quarterly earnings results on Thursday, August 8th.
According to Zacks, analysts expect that MAXIMUS will report full year earnings of $3.70 per share for the current fiscal year, with EPS estimates ranging from $3.68 to $3.72. For the next financial year, analysts forecast that the business will report earnings of $4.13 per share, with EPS estimates ranging from $4.00 to $4.29. Zacks’ EPS calculations are a mean average based on a survey of research firms that cover MAXIMUS.
MAXIMUS (NYSE:MMS) last released its earnings results on Thursday, May 9th. The health services provider reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.05. The company had revenue of $736.50 million for the quarter, compared to the consensus estimate of $757.29 million. MAXIMUS had a net margin of 8.76% and a return on equity of 21.19%. MAXIMUS’s revenue was up 20.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.84 EPS.
In other MAXIMUS news, Director Russell A. Beliveau sold 1,000 shares of MAXIMUS stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $71.40, for a total transaction of $71,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.20% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Oregon Public Employees Retirement Fund lifted its stake in MAXIMUS by 6,329.9% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,656,085 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 1,630,329 shares during the period. Quantamental Technologies LLC acquired a new position in shares of MAXIMUS in the 4th quarter valued at $38,000. Omnia Family Wealth LLC acquired a new position in shares of MAXIMUS in the 4th quarter valued at $41,000. Mckinley Capital Management LLC Delaware acquired a new position in shares of MAXIMUS in the 1st quarter valued at $44,000. Finally, Advisor Group Inc. lifted its stake in shares of MAXIMUS by 47.3% in the 4th quarter. Advisor Group Inc. now owns 869 shares of the health services provider’s stock valued at $56,000 after purchasing an additional 279 shares during the period. Institutional investors and hedge funds own 94.37% of the company’s stock.
NYSE:MMS opened at $75.56 on Monday. The company has a market cap of $4.76 billion, a price-to-earnings ratio of 22.22, a P/E/G ratio of 2.01 and a beta of 0.92. MAXIMUS has a twelve month low of $60.00 and a twelve month high of $75.58. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.06.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 1.32%. The ex-dividend date was Tuesday, May 14th. MAXIMUS’s payout ratio is 29.41%.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Further Reading: Strike Price
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.